Moleculin Biotech (MBRX) Misses Q2 EPS by 49c

Moleculin Biotech (NASDAQ: MBRX) reported Q2 EPS of ($0.49).

For earnings history and earnings-related data on Moleculin Biotech (MBRX) click here.

You May Also Be Interested In

• Wolfe Research Upgrades Janux Therapeutics (JANX) to Outperform, 'An ARM Out of the Penalty Box'
• Morgan Stanley Downgrades Telekom Malaysia Bhd (T:MK) (MYTEF) to Equalweight
• Baird Starts Jersey Mike's Subs (JMKE) at Outperform